Spermatogenesis and Semen Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-05-16
Clinical Trial Update: Composition for Treating Spermatogenesis and Semen Disorders / FPT-20 [Phase 4]
A Phase 4 clinical trial (NCT05399212) evaluating a composition called FPT-20 for spermatogenesis and semen disorders has completed.